1. Prevention of Alzheimer’s Disease in Chinese Populations: Status, Challenges and Directions

   • Lei Feng
   • J. Li
   • Chunbo Li

   Editorial 21 March 2018 Pages: 90 - 94

2. Diabetes Mellitus and Cognitive Decline – Prevention Should Not Be Delayed!

   • Alan J. Sinclair
   • B. Vellas

   Editorial 20 February 2018 Pages: 95 - 97

3. Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force

   • Mary Sano
   • M. Soto
   • EU/US/CTAD Task Force members

   CTAD Task Force Paper 27 March 2018 Pages: 98 - 102

4. Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer’s Disease Task Force

   • Jeffrey Cummings
   • N. Fox
   • EU/US Alzheimer’ Disease Task Force

   Brief Report 16 March 2018 Pages: 103 - 109

5. Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease

   • J. Luo
   • H. Weng
   • Chengjie Xiong

   Brief Report 16 March 2018 Pages: 110 - 119

6. A Literature Review of Methodologies Used in Randomized Clinical Trials of Agitation in Alzheimer’s Disease

   • Sanjay Dubé
   • J. T. Megerian
   • R. Malamut

   Brief Report 16 March 2018 Pages: 120 - 133

7. The Integrated Alzheimer’s Disease Rating Scale (iADRS) Findings from the EXPEDITION3 Trial

   • Alette M. Wessels
   • S. W. Andersen
   • E. R. Siemers

   Original Research 20 February 2018 Pages: 134 - 136

8. Adherence to the Mediterranean Diet Is not Related to Beta-Amyloid Deposition: Data from the Women’s Healthy Ageing Project

   • E. Hill
   • Cassandra Szoeke
   • P. Clifton

   Original Research 27 February 2018 Pages: 137 - 141

9. Strong Relationship between Malnutrition and Cognitive Frailty in the Singapore Longitudinal Ageing Studies (SLAS-1 and SLAS-2)

   • L. Chye
   • K. Wei
   • Tze-Pin Ng

   Original Research 05 December 2017 Pages: 142 - 148

10. Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer’s Disease

    • A. H. Burstein
    • M. Sabbagh
    • Larry Altstiel

    Review 22 March 2018 Pages: 149 - 154

11. Nanorobots the Future of Neurology: A Perspective on Alzheimer’s Disease

    • Claudie Hooper
    • S. Layé

    Letter to Editor 20 February 2018 Pages: 155 - 156